If screening applications resemble a scientific or economic bottleneck in your company, a very unique approach can help: Autodisplay Biotech GmbH's proprietary technologies pMATE and Autodisplay enable the development of cost-efficient screening tools, which can be used for the identification of binding partners such as inhibitors, activators, biomarkers or autoantigens. We use fluorescence marked libraries in order to identify targets. Any binding activity can then be selected through fluorescence activated cell sorting (FACS). Find out how our custom-tailored products and services can assist in bringing your research forward.